1. Home
  2. PLXS vs AMRX Comparison

PLXS vs AMRX Comparison

Compare PLXS & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLXS
  • AMRX
  • Stock Information
  • Founded
  • PLXS 1979
  • AMRX 2002
  • Country
  • PLXS United States
  • AMRX United States
  • Employees
  • PLXS N/A
  • AMRX N/A
  • Industry
  • PLXS Electrical Products
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLXS Technology
  • AMRX Health Care
  • Exchange
  • PLXS Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • PLXS 3.7B
  • AMRX 3.7B
  • IPO Year
  • PLXS 1986
  • AMRX N/A
  • Fundamental
  • Price
  • PLXS $145.11
  • AMRX $12.53
  • Analyst Decision
  • PLXS Buy
  • AMRX Buy
  • Analyst Count
  • PLXS 4
  • AMRX 3
  • Target Price
  • PLXS $157.50
  • AMRX $12.67
  • AVG Volume (30 Days)
  • PLXS 171.4K
  • AMRX 1.9M
  • Earning Date
  • PLXS 10-22-2025
  • AMRX 10-30-2025
  • Dividend Yield
  • PLXS N/A
  • AMRX N/A
  • EPS Growth
  • PLXS 56.11
  • AMRX N/A
  • EPS
  • PLXS 6.26
  • AMRX 0.02
  • Revenue
  • PLXS $4,032,966,000.00
  • AMRX $2,934,959,000.00
  • Revenue This Year
  • PLXS $10.81
  • AMRX $10.20
  • Revenue Next Year
  • PLXS $7.18
  • AMRX $6.95
  • P/E Ratio
  • PLXS $22.98
  • AMRX $667.09
  • Revenue Growth
  • PLXS 1.82
  • AMRX 9.50
  • 52 Week Low
  • PLXS $103.43
  • AMRX $6.69
  • 52 Week High
  • PLXS $172.89
  • AMRX $12.58
  • Technical
  • Relative Strength Index (RSI)
  • PLXS 55.07
  • AMRX 73.94
  • Support Level
  • PLXS $132.03
  • AMRX $11.45
  • Resistance Level
  • PLXS $142.35
  • AMRX $11.91
  • Average True Range (ATR)
  • PLXS 5.04
  • AMRX 0.34
  • MACD
  • PLXS 0.27
  • AMRX 0.05
  • Stochastic Oscillator
  • PLXS 85.59
  • AMRX 97.64

About PLXS Plexus Corp.

Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: